|
Name |
2-Hexyl-1-decanol
|
Molecular Formula | C16H34O | |
IUPAC Name* |
2-hexyldecan-1-ol
|
|
SMILES |
CCCCCCCCC(CCCCCC)CO
|
|
InChI |
InChI=1S/C16H34O/c1-3-5-7-9-10-12-14-16(15-17)13-11-8-6-4-2/h16-17H,3-15H2,1-2H3
|
|
InChIKey |
XULHFMYCBKQGEE-UHFFFAOYSA-N
|
|
Synonyms |
2-Hexyl-1-decanol; 2425-77-6; 2-Hexyldecan-1-ol; 1-Decanol, 2-hexyl-; 2-Hexyldecanol; 2-Hexyldecyl Alcohol; Guerbitol 16; Isofol 16; Rilanit G 16; Exxal 16; NSC 2399; MFCD00060903; NSC-2399; 151Z7P1317; Guerbet Hexadecanol; Guerbet C16; Jarcol I 16; NJCOL 160BRA; NJCOL 160BR; NSC2399; UNII-151Z7P1317; EINECS 219-370-1; 2-octyl-1-octanol; AI3-19964; EC 219-370-1; HEXYLDECANOL [INCI]; JARCOL I-16; DSSTox_CID_21265; DSSTox_RID_79669; DSSTox_GSID_41265; SCHEMBL15863; 2-Hexyl-1-decanol, 97%; NJCOL 160; CHEMBL3560208; DTXSID1041265; CHEBI:183266; Tox21_300799; AKOS015912415; CS-W012764; NCGC00248173-01; NCGC00254703-01; AS-46984; SY034340; CAS-2425-77-6; FT-0669198; H1461; F11131; A877978; J-509560; Q27251672
|
|
CAS | 2425-77-6 | |
PubChem CID | 95337 | |
ChEMBL ID | CHEMBL3560208 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 242.44 | ALogp: | 7.0 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 13 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 20.2 | Aromatic Rings: | 0 |
Heavy Atoms: | 17 | QED Weighted: | 0.419 |
Caco-2 Permeability: | -4.484 | MDCK Permeability: | 0.00001350 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.192 |
30% Bioavailability (F30%): | 0.974 |
Blood-Brain-Barrier Penetration (BBB): | 0.077 | Plasma Protein Binding (PPB): | 98.10% |
Volume Distribution (VD): | 2.429 | Fu: | 1.59% |
CYP1A2-inhibitor: | 0.578 | CYP1A2-substrate: | 0.212 |
CYP2C19-inhibitor: | 0.415 | CYP2C19-substrate: | 0.078 |
CYP2C9-inhibitor: | 0.213 | CYP2C9-substrate: | 0.839 |
CYP2D6-inhibitor: | 0.231 | CYP2D6-substrate: | 0.107 |
CYP3A4-inhibitor: | 0.313 | CYP3A4-substrate: | 0.07 |
Clearance (CL): | 5.515 | Half-life (T1/2): | 0.177 |
hERG Blockers: | 0.176 | Human Hepatotoxicity (H-HT): | 0.016 |
Drug-inuced Liver Injury (DILI): | 0.031 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.013 | Maximum Recommended Daily Dose: | 0.024 |
Skin Sensitization: | 0.945 | Carcinogencity: | 0.034 |
Eye Corrosion: | 0.974 | Eye Irritation: | 0.959 |
Respiratory Toxicity: | 0.436 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001235 | 0.875 | D07ILQ | 0.421 | ||||
ENC000272 | 0.640 | D05ATI | 0.418 | ||||
ENC000421 | 0.635 | D0Z5SM | 0.417 | ||||
ENC000517 | 0.632 | D0O1PH | 0.390 | ||||
ENC000422 | 0.630 | D00AOJ | 0.386 | ||||
ENC000968 | 0.627 | D00MLW | 0.361 | ||||
ENC000423 | 0.625 | D0T9TJ | 0.352 | ||||
ENC003063 | 0.614 | D0XN8C | 0.338 | ||||
ENC000473 | 0.612 | D0P1RL | 0.337 | ||||
ENC001247 | 0.607 | D00FGR | 0.337 |